Duration of Action of Concerta (Methylphenidate)
Pharmacokinetics and Mechanism of Action
- Concerta utilizes an osmotically released, timed drug-delivery system (OROS) that produces an ascending-pattern plasma drug level throughout the day 1
- Unlike immediate-release methylphenidate which has a half-life of approximately 2 hours, Concerta is designed to provide extended coverage 2
- Concerta begins working within 1-2 hours after ingestion, with effects lasting for a full 12-hour period 3
Comparison with Other Methylphenidate Formulations
- Standard immediate-release methylphenidate requires multiple daily dosing (typically 2-3 times daily) with effects lasting only about 4 hours per dose 2
- Older sustained-release formulations (e.g., MPH-SR20) provide approximately 4-6 hours of clinical action 2
Dosing Considerations
- Concerta is available in 18 mg, 36 mg, and 54 mg strengths for once-daily administration 1
- The 18 mg dose of Concerta is approximately equivalent to methylphenidate 5 mg three times daily 1
- Morning administration is recommended to minimize potential sleep disturbances 4
Clinical Implications and Pitfalls
- Common pitfall: Expecting immediate onset of action, unlike immediate-release methylphenidate, Concerta has a more gradual onset of effect 3
Special Populations
- In adolescents, Concerta's 12-hour duration and once-daily dosing may improve compliance and reduce risk of medication diversion 5
- For adults with ADHD, the extended 12-hour coverage supports functioning throughout the workday and into evening activities 4
Concerta Dosing and Monitoring for Adults with ADHD
Initial Dosing and Titration
- The American Academy of Child and Adolescent Psychiatry suggests that adults with ADHD often require higher total daily doses than children because they need symptom coverage throughout a longer workday 6
- ADHD symptom severity should be monitored using standardized rating scales, with clinical response typically occurring within 1-2 hours of administration and lasting for the full 12-hour period, with approximately 66% of adults achieving clinical response with optimal dosing 6
Response Assessment and Dose Adjustment
- If no response occurs after 4 weeks at maximum tolerated dose, consider switching to an alternative stimulant, according to the American Academy of Child and Adolescent Psychiatry 6
- Adults may require doses above 72 mg, but this should be documented clearly, noting that lower doses were inadequate and higher doses are not producing prohibitive side effects 6